Page last updated: 2024-09-05

l 778,123 and Cancer of Pancreas

l 778,123 has been researched along with Cancer of Pancreas in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernhard, EJ; Brunner, TB; DeLaney, TF; Deutsch, P; Gupta, AK; Hahn, SM; Haller, DG; Kiel, KD; Martin, NE; McKenna, WG; Mohiuddin, M; Morrison, B; Muschel, RJ; Pramanik, B; Regine, WF; Rosato, EF; Smith, D; Stevenson, JP; Tanaka, WK; Tepper, J	1
Buser, CA; Dinsmore, CJ; Fernandes, C; Greenberg, I; Hamilton, K; Koblan, KS; Mosser, SD; Walsh, ES; Williams, TM	1

Trials

1 trial(s) available for l 778,123 and Cancer of Pancreas

Article	Year
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Aug-15, Volume: 10, Issue:16 Topics: Adult; Aged; Alkyl and Aryl Transferases; Cell Line, Tumor; Combined Modality Therapy; Dose-Response Relationship, Drug; Farnesyltranstransferase; Female; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Pancreatic Neoplasms; Survival Analysis; Time Factors	2004

Article

Year

A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Aug-15, Volume: 10, Issue:16

Topics: Adult; Aged; Alkyl and Aryl Transferases; Cell Line, Tumor; Combined Modality Therapy; Dose-Response Relationship, Drug; Farnesyltranstransferase; Female; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Pancreatic Neoplasms; Survival Analysis; Time Factors

2004

Other Studies

1 other study(ies) available for l 778,123 and Cancer of Pancreas

Article	Year
High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123. Analytical biochemistry, 2001, Mar-01, Volume: 290, Issue:1 Topics: Alkyl and Aryl Transferases; Dimethylallyltranstransferase; Enzyme Inhibitors; Farnesyltranstransferase; Gas Chromatography-Mass Spectrometry; Humans; Imidazoles; Pancreatic Neoplasms; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Recombinant Proteins; Tumor Cells, Cultured	2001

Article

Year

High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123.

Analytical biochemistry, 2001, Mar-01, Volume: 290, Issue:1

Topics: Alkyl and Aryl Transferases; Dimethylallyltranstransferase; Enzyme Inhibitors; Farnesyltranstransferase; Gas Chromatography-Mass Spectrometry; Humans; Imidazoles; Pancreatic Neoplasms; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Recombinant Proteins; Tumor Cells, Cultured

2001